
AI Creates Novel Viruses, Raising Biosafety Concerns
Scientists have successfully used artificial intelligence to create entirely new, functional viruses not found in nature, including antibacterial viruses. While this breakthrough offers potential for new therapies, experts are warning of significant biosafety risks and the potential for misuse.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (76/100)Sources
Artificial Intelligence used to design brand new viruses
Scientists made 16 successful viruses that had their genetic code designed by artificial intelligence.
Read full article →This A.I. Just Created Viruses Not Found in Nature
Scientists trained artificial intelligence on libraries of DNA and then asked the model to create recipes for viral genomes. Sixteen of them were viable, yielding new viruses.
By Carl Zimmer
Read full article →AI creates first synthetic viruses
Genomic language model has huge potential to redesign organisms such as bacteria
Read full article →Safety fears as scientists make first viruses designed by AI
Researchers say breakthrough offers hope for new medicines but also raises urgent biosecurity questions Scientists have made the first viruses designed by artificial intelligence in a milestone that raises hopes for new medicines but also concerns over how to ensure the technology remains safe. The viruses are specific kinds known as bacteriophages, which only infect bacteria and are used around the world to treat patients with persistent infections. In lab tests, a cocktail of the AI-designe...
By Ian Sample Science editor
Read full article →Nothing to fear: AI just created a virus that is not found in nature
The results have inspired equal parts hope and terror about the future of AI-inflected biology
By Josh Marcus
Read full article →Scientists Trained An AI Model In DNA—And It Invented 16 New Viruses
Scientists are worried about how smart DNA-trained artificial intelligence models could get—and that they could become a weapon in biological warfare.
By Mary Whitfill Roeloffs, Forbes Staff
Read full article →